{"schema_version":"secwatch.filing_event.v1","accession":"0000937556-24-000015","form_type":"8-K","ticker":"MASI","cik":"0000937556","company_name":"MASIMO CORP","filed_at":"2024-02-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:27.364336+00:00","generated_at":"2026-06-05T14:02:54.736304+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Masimo Q4 revenue $548.9M, GAAP EPS $0.63; full-year $2,048.1M; FY2024 guidance $2,045-2,165M","bullets":["Q4 consolidated revenue $548.9M (healthcare $339.9M, non-healthcare $209.0M).","GAAP EPS $0.63; non-GAAP EPS (updated) $1.25.","Full-year 2023 revenue $2,048.1M; GAAP EPS $1.51; non-GAAP EPS $3.79.","Q1 2024 guidance: revenue $476-501M; full-year 2024 revenue $2,045-2,165M.","CEO cites record contract wins, FDA clearances, and hearables growth as momentum drivers."],"urls":{"canonical":"https://secwatch.observer/filing/0000937556-24-000015","json":"https://secwatch.observer/filing/0000937556-24-000015.json","markdown":"https://secwatch.observer/filing/0000937556-24-000015.md","text":"https://secwatch.observer/filing/0000937556-24-000015.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/937556/000093755624000015/0000937556-24-000015-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/937556/000093755624000015/masi-20240227.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T14:02:54.736304+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5693027c43fc330384b975f3f91e7bbd65341bf1","claim":"MASIMO CORP reported Full-Year 2023 results: revenue $2,048.1 million, net income $81.5 million, EPS $1.51.","evidence_excerpt":"Consolidated revenue was $2,048.1 million, consisting of healthcare revenue of $1,275.5 million and non-healthcare revenue of $772.6 million. Excluding handheld and fingertip pulse oximeters, shipments of noninvasive technology boards and instruments were 263,000. Consolidated GAAP operating income was $136.5 million. Consolidated non-GAAP operating income (prior definition) was $269.6 million. Consolidated non-GAAP operating income (updated definition) was $313.0 million. Consolidated GAAP net income was $81.5 million, or $1.51 per diluted share.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/937556/000093755624000015/0000937556-24-000015-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"Full-Year 2023"},{"label":"Revenue","value":"$2,048.1 million"},{"label":"Net income","value":"$81.5 million"},{"label":"EPS","value":"$1.51"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"b7ebc9c5ea8c421ee20891abe07ebbefa88b310e","claim":"MASIMO CORP reported Fourth Quarter 2023 results: revenue $548.9 million, net income $34.0 million, EPS $0.63.","evidence_excerpt":"Consolidated revenue was $548.9 million, comprised of healthcare revenue of $339.9 million and non-healthcare revenue of $209.0 million. Excluding handheld and fingertip pulse oximeters, shipments of noninvasive technology boards and instruments were 58,500. Consolidated GAAP operating income was $44.1 million. Consolidated non-GAAP operating income (prior definition) was $78.6 million. Consolidated non-GAAP operating income (updated definition) was $91.7 million. Consolidated GAAP net income was $34.0 million, or $0.63 per diluted share.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/937556/000093755624000015/0000937556-24-000015-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"Fourth Quarter 2023"},{"label":"Revenue","value":"$548.9 million"},{"label":"Net income","value":"$34.0 million"},{"label":"EPS","value":"$0.63"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}